Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
Inside Poe Hall: The chemicals and where they were found
Recommended
Climate change is stealing winter in North Carolina
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Yield10 Bioscience, Inc. - Common Stock
(NQ:
YTEN
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, May 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Yield10 Bioscience, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Yield10 Bioscience's Return On Capital Employed Insights
March 15, 2023
Via
Benzinga
A Preview Of Yield10 Bioscience's Earnings
March 13, 2023
Via
Benzinga
Why Yield10 Bioscience Stock Is Taking Off Thursday
March 02, 2023
Yield10 Bioscience Inc (NASDAQ: YTEN) shares are trading higher Thursday after the company signed a Memorandum of Understanding (MOU)<
Via
Benzinga
Yield10 Bioscience to Present at the Third Annual Winter Wonderland - Best Ideas 2023 Virtual Conference on February 21, 2023
February 16, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Intraday Session
January 12, 2023
Via
Benzinga
US Stocks Turn Higher; Dow Jumps 200 Points
January 12, 2023
U.S. stocks turned higher midway through trading, following the release of inflation data.
Via
Benzinga
Yield10 Bioscience: Q2 Earnings Insights
August 10, 2022
Yield10 Bioscience (NASDAQ:YTEN) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Yield10 Bioscience: Q1 Earnings Insights
May 11, 2022
Yield10 Bioscience (NASDAQ:YTEN) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
May 11, 2022
On Wednesday, 807 companies reached new 52-week lows.
Via
Benzinga
Earnings Scheduled For May 11, 2022
May 11, 2022
Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter.
Via
Benzinga
Why KNOT Offshore Partners Shares Are Trading Lower By Around 38%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 12, 2023
Gainers BigBear.ai Holdings, Inc. (NYSE: BBAI) shares jumped 239% to $2.8715 after the company announced it has been awarded a multiple award $900 million Indefinite Delivery/Indefinite Quantity...
Via
Benzinga
Dow Drops 150 Points; US Inflation Rate Slows In December
January 12, 2023
U.S. stocks traded lower this morning, following the release of inflation data.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 12, 2023
Via
Benzinga
Why Akerna Shares Are Trading Higher By 97%; Here Are 20 Stocks Moving Premarket
January 12, 2023
Gainers Akerna Corp. (NASDAQ: KERN) rose 97.4% to $1.91 in pre-market trading after the company reported the sale of 365 Cannabis for $2.8 million.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
January 12, 2023
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Thursday!
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 11, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 27, 2022
Via
Benzinga
Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session
December 07, 2022
Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC...
Via
Benzinga
Yield10 Bioscience to Present at the MicroCap Rodeo Presents: Windy City Roundup 2022 on October 12
October 06, 2022
Via
ACCESSWIRE
Earnings Scheduled For November 14, 2022
November 14, 2022
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
Via
Benzinga
Why Laser Photonics Shares Surged By Around 19%; Here Are 70 Biggest Movers From Friday
October 17, 2022
Gainers Agrify Corporation (NASDAQ: AGFY) climbed 53.8% to close at $1.45. FedNat Holding Company (NASDAQ: FNHC) gained 48% to settle at $0.52.
Via
Benzinga
60+ Companies to Present at the 2nd Annual MicroCap Rodeo - Windy City Roundup Conference on October 12th - 13th, 2022 in Chicago
September 27, 2022
Via
ACCESSWIRE
Why Minerva Neurosciences Shares Traded Higher By Over 66%; Here Are 78 Biggest Movers From Yesterday
August 25, 2022
Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) shares gained 66.5% to close at $7.51 after Point72 Asset Management reported an 8.8% passive stake in the company.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
August 24, 2022
Via
Benzinga
Why XPeng Shares Traded Lower By Around 11%; Here Are 77 Biggest Movers From Yesterday
August 24, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 23, 2022
Via
Benzinga
Why Windtree Therapeutics Is Trading Higher By Over 60%, Here Are 61 Stocks Moving In Tuesday's Mid-Day Session
August 23, 2022
Gainers
Via
Benzinga
Earnings Scheduled For August 10, 2022
August 10, 2022
Companies Reporting Before The Bell • Wix.com (NASDAQ:WIX) is estimated to report earnings for its second quarter.
Via
Benzinga
Earnings Outlook For Yield10 Bioscience
August 09, 2022
Yield10 Bioscience (NASDAQ:YTEN) is set to give its latest quarterly earnings report on Wednesday, 2022-08-10. Here's what investors need to know before the announcement.
Via
Benzinga
Yield10 Bioscience Earnings Perspective: Return On Capital Employed
June 16, 2022
Benzinga Pro data, Yield10 Bioscience (NASDAQ:YTEN) reported Q1 sales of $149.00 thousand. Earnings fell to a loss of $3.33 million, resulting in a 11.78% decrease from last quarter.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.